Index 
 Previous 
 Next 
 Full text 
Procedure : 2019/2825(RSP)
Document stages in plenary
Document selected : B9-0103/2019

Texts tabled :

B9-0103/2019

Debates :

Votes :

PV 10/10/2019 - 8.5

Texts adopted :

P9_TA(2019)0026

Minutes
XML 2k
Thursday, 10 October 2019 - Brussels

8.5. Objection pursuant to Rule 112: Active substances, including flumioxazine (vote)

Motion for a resolution tabled by the ENVI Committee, in accordance with Rule 112(2) and (3), on Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole (2019/2825(RSP)) (B9-0103/2019) - Member responsible: Anja Hazekamp

(Simple majority needed)
(Voting record: 'Results of votes', Item 5)

MOTION FOR A RESOLUTION

Adopted (P9_TA(2019)0026)

Last updated: 21 January 2020Legal notice - Privacy policy